By L. Gonzales. Simpson College, Indianola Iowa. 2018.
In addition generic clonidine 0.1mg on line heart attack from weed, within published intervention studies best clonidine 0.1 mg hypertension workup, the impact of poorly defined interventions was regarded as twofold: first, the synthesis of findings in evidence reviews may not be reliable, and, second, it prevents replication. The context of multiple, simultaneous interventions Many study participants described the multifaceted nature of the care of many children with neurodisability, especially those with more severe or complex impairments. In these instances, it is likely that a number of professions will be involved and the child may be receiving multiple interventions. It was noted that this may present challenges for evaluation studies, and would need to be controlled or accounted for:. I2 Research design issues There was a range of beliefs among participants about how therapy interventions could, or should, be evaluated. It should be noted that, quite understandably, sometimes these beliefs were based on a limited understanding of research. We have been circumspect, therefore, in how we report the issues and concerns about the design of evaluation research expressed by participants. Some issues relevant to this topic have already been explored, or have been placed in Chapter 10 on research priorities, and we do not therefore cover them again here. This includes issues related to outcome, outcome measurement and follow-up points (see Chapter 7), and the measurement of active ingredients (see Chapter 10). The feasibility of trials Among interviewees who had some degree of experience of designing or conducting evaluations, trials were usually, although not always, regarded as an appropriate and/or feasible study design for some research questions or objectives. Rather than oversimplifying the [analysis] to: did the therapy make a difference, or not? This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals 71 provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton SO16 7NS, UK. K1 Comparator groups Across all three therapies and across a range of settings, participants said that it may not be possible, or ethical, to withhold treatment to create a no-treatment comparator. A rhetoric of equipoise was not presented within these reflections: Within the population we see, it would not be feasible to have a control where we are doing nothing; there would have to be another sort of comparator. The potential of non-experimental study designs Non-experimental study designs were viewed as having the potential to make a strong contribution to the evidence base on intervention effectiveness, and neurodisability per se. Particular reference was made to case studies and long-term cohort studies. A while ago I was trying to set up a study and was told by a medical statistician there needed to be a plague of cerebral palsy for me to do it. So we need to be more accepting of what are the appropriate methodologies. N2 With respect to cohort studies, participants highlighted potential opportunities within the newly established Children and Young People Health Services Data Set (http://content. A number of interviewees also mooted the benefits of adopting of the hip surveillance strategy for children with cerebral palsy, which had been implemented recently in Scotland: Epidemiological data is very important. For participation, you need to look at cohorts in the longer term, so 10-plus years. X1 A number of interviewees noted the potential value of developing clear protocols for reporting case studies, which, if there was some sort of national repository, would allow the collation and synthesis of evidence. Research investment to support such initiatives, and ensure that they are robust and properly 72 NIHR Journals Library www. It was also noted that case studies offered a means by which frontline therapists could actively engage in, and contribute to, research, thereby increasing the research capacity within the profession. J1 The final sections of this chapter consider two further challenges: implementing evaluation studies in practice and securing research funding. Challenges associated with implementing evaluation studies Intervention adherence There was strong consensus that research on therapies has to be practice based, rather than consisting of contrived clinic-based studies of efficacy. The latter, it was felt, do not reflect the true complexity of therapy interventions for children with neurodisability.
The source of fund- creased 1 generic 0.1mg clonidine visa blood pressure medication lightheadedness,000-fold generic 0.1 mg clonidine mastercard heart attack kiss, something is wrong with the model. This simula- ADMINISTRATIVE DATABASES tion was reported very explicitly and so is transparent and could be replicated by others. When the model was repli- Retrospective administrative database studies are a source cated, a design flaw was discovered and unrealistic assump- of data on antidepressant costs and efficacy in actual clinical tions were identified that drove the results (29). In these studies, computerized pharmacy and ser- of the design flaw and substitution of longer treatment vice utilization records are used to analyze cost outcomes lengths recommended by practice guidelines reversed the as a function of clinical assignment to antidepressant. Retro- findings and yielded a cost-effectiveness advantage in favor spective studies are less expensive than prospective trials and of the TCAs. These same corrections could be applied to can be conducted more quickly. However, they are much the other simulations that depended on the early example. These studies are vulnerable to similar significant problems with 67% of the pharmacoeco- 'selection bias. Apparent is relatively common in the studies shown in Tables 78. In general, the longer treatment with antidepres- of changing trends in practice over time (40). As a result, they generally assume a worst treatment period progressively increases the medication ac- case of equivalent outcomes for the newer antidepressants quisition costs associated with newer antidepressants. By and the older antidepressants and then defined the more contrast, much of the greater cost of treatment delivery of cost-effective care as the treatment associated with lower the older drugs is expended early in treatment, in visits overall costs of health care. A newer antidepressant can be 1128 1129 1130 Neuropsychopharmacology: The Fifth Generation of Progress associated with lower overall costs of health care if the higher when care was not so firmly managed, and a higher propor- acquisition costs are more than offset by lower costs for tion of fluoxetine starts may have occurred later in the study other services. This type of cost-effectiveness analysis is period, when visits and hospitalizations were more carefully known as cost minimization. Thus, cost savings in later years could erro- A few of the administrative database studies have con- neously be attributed to fluoxetine that are really a conse- structed proxy outcome measures based on pharmacy refill quence of tighter management. The distribution of fluoxe- data, such as 'number of prescriptions refilled' (41). For tine and TCA starts within the study period was not example, one study used pharmacy claims to determine the reported. This study found have included time of the antidepressant start within the fluoxetine to be associated with longer continuation on study interval as an explanatory variable in the analysis, but medication and costs similar to those of the comparison they appear to have restricted attention primarily to its effect groups. The authors concluded that fluoxetine is cost-effec- on initial selection of antidepressant. No study presents data tive because adherence to treatment guidelines is better with indicating whether health care costs associated with antide- no increment in cost. Other retrospective analyses have re- pressant starts were increasing or decreasing during the ported similar natural course of therapy findings but base study interval, or how a secular cost trend, if present, may a judgment of cost-effectiveness on finding a reduction in have interacted with the distribution of starts of individual overall 'depression-related' health care costs (42,43). We briefly review the designs and results of available Other important limitations in the studies in Table 78. The first study comparing a newer non-SSRI with control antidepres- three studies, which sampled data from 1989 to 1994, found sants. These tables indicate for each study the sample size fluoxetine to be more cost-effective than sertraline or more in the administrative database, the time interval over which cost-effective than sertraline and paroxetine. A type of selec- data were sampled, the type of patient population, the newer tion bias that has been termed launch bias may have affected and control antidepressants analyzed, the stated principal these findings (46). The time frames of these studies over- economic outcome measure, the overall results on that out- lapped with the first year or two after launch of sertraline come measure as interpreted by the authors, and a brief and paroxetine. It is possible that a new antidepressant is discussion of methodologic limitations. One small pilot prescribed for a different type of patient in the early years study is not included in Table 78. Patients selected by their physicians to receive portedly found fluoxetine to be cost-effective in comparison a brand-new antidepressant may generally be more severely with TCAs (Skaer et al.
The Public Health Research programme also complements the NIHR Health Technology Assessment programme which has a growing portfolio evaluating NHS public health interventions cheap clonidine 0.1 mg otc prehypertension facts. For more information about the PHR programme please visit the website: http://www clonidine 0.1 mg line blood pressure quiz nursing. The final report began editorial review in November 2016 and was accepted for publication in February 2017. The authors have been wholly responsible for all data collection, analysis and interpretation, and for writing up their work. However, they do not accept liability for damages or losses arising from material published in this report. This report presents independent research funded by the National Institute for Health Research (NIHR). The views and opinions expressed by authors in this publication are those of the authors and do not necessarily reflect those of the NHS, the NIHR, NETSCC, the PHR programme or the Department of Health. If there are verbatim quotations included in this publication the views and opinions expressed by the interviewees are those of the interviewees and do not necessarily reflect those of the authors, those of the NHS, the NIHR, NETSCC, the PHR programme or the Department of Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton SO16 7NS, UK. Public Health Research Editor-in-Chief Professor Martin White Director of Research and Programme Leader, UKCRC Centre for Diet and Activity Research (CEDAR), MRC Epidemiology Unit, Institute of Metabolic Science, School of Clinical Medicine, University of Cambridge; Visiting Professor, Newcastle University; and Director, NIHR Public Health Research Programme NIHR Journals Library Editor-in-Chief Professor Tom Walley Director, NIHR Evaluation, Trials and Studies and Director of the EME Programme, UK NIHR Journals Library Editors Professor Ken Stein Chair of HTA and EME Editorial Board and Professor of Public Health, University of Exeter Medical School, UK Professor Andrée Le May Chair of NIHR Journals Library Editorial Group (HS&DR, PGfAR, PHR journals) Dr Martin Ashton-Key Consultant in Public Health Medicine/Consultant Advisor, NETSCC, UK Professor Matthias Beck Professor of Management, Cork University Business School, Department of Management and Marketing, University College Cork, Ireland Dr Tessa Crilly Director, Crystal Blue Consulting Ltd, UK Dr Eugenia Cronin Senior Scientiﬁc Advisor, Wessex Institute, UK Dr Peter Davidson Director of the NIHR Dissemination Centre, University of Southampton, UK Ms Tara Lamont Scientiﬁc Advisor, NETSCC, UK Dr Catriona McDaid Senior Research Fellow, York Trials Unit, Department of Health Sciences, University of York, UK Professor William McGuire Professor of Child Health, Hull York Medical School, University of York, UK Professor Geoffrey Meads Professor of Wellbeing Research, University of Winchester, UK Professor John Norrie Chair in Medical Statistics, University of Edinburgh, UK Professor John Powell Consultant Clinical Adviser, National Institute for Health and Care Excellence (NICE), UK Professor James Raftery Professor of Health Technology Assessment, Wessex Institute, Faculty of Medicine, University of Southampton, UK Dr Rob Riemsma Reviews Manager, Kleijnen Systematic Reviews Ltd, UK Professor Helen Roberts Professor of Child Health Research, UCL Institute of Child Health, UK Professor Jonathan Ross Professor of Sexual Health and HIV, University Hospital Birmingham, UK Professor Helen Snooks Professor of Health Services Research, Institute of Life Science, College of Medicine, Swansea University, UK Professor Jim Thornton Professor of Obstetrics and Gynaecology, Faculty of Medicine and Health Sciences, University of Nottingham, UK Professor Martin Underwood Director, Warwick Clinical Trials Unit, Warwick Medical School, University of Warwick, UK Please visit the website for a list of members of the NIHR Journals Library Board: www. There is little evidence of effective obesity prevention programmes for children in this age group. Objective: To determine the effectiveness and cost-effectiveness of a school-based healthy lifestyles programme in preventing obesity in children aged 9–10 years. Design: A cluster randomised controlled trial with an economic and process evaluation. Setting: Thirty-two primary schools in south-west England. Intervention: The Healthy Lifestyles Programme (HeLP) ran during the spring and summer terms of Year 5 into the autumn term of Year 6 and included four phases: (1) building a receptive environment, (2) a drama-based healthy lifestyles week, (3) one-to-one goal setting and (4) reinforcement activities. Main outcome measures: The primary outcome measure was body mass index (BMI) standard deviation score (SDS) at 24 months post baseline measures (12 months post intervention). The secondary outcomes comprised waist circumference SDS, percentage body fat SDS, proportion of children overweight and obese at 18 and 24 months, accelerometer-assessed physical activity and food intake at 18 months, and cost-effectiveness. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals vii provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton SO16 7NS, UK. ABSTRACT Results: We recruited 32 schools and 1324 children. We had a rate of 94% follow-up for the primary outcome. No difference in BMI SDS was found at 24 months [mean difference –0. No difference was found between the intervention and control groups in waist circumference SDS, percentage body fat SDS or physical activity levels. Self-reported dietary behaviours showed that, at 18 months, children in the intervention schools consumed fewer energy-dense snacks and had fewer negative food markers than children in the control schools. The cost of implementing the intervention was approximately £210 per child. The intervention was not cost-effective compared with control. The programme was delivered with high fidelity, and it engaged children, schools and families across the socioeconomic spectrum. Limitations: The rate of response to the parent questionnaire in the process evaluation was low. Although the schools in the HeLP study included a range of levels of socioeconomic deprivation, class sizes and rural and urban settings, the number of children for whom English was an additional language was considerably lower than the national average. Conclusions: HeLP is not effective or cost-effective in preventing overweight or obesity in children aged 9–10 years.
A recent study (Moreira et al discount 0.1mg clonidine otc blood pressure scale, 2017) used MRI and presents an integration of structural and functional observations order clonidine 0.1 mg mastercard blood pressure chart sleeping. OCD patients showed volume reductions in the right superior temporal sulcus. They also showed decreased functional connectivity (FC) (the functionally integrated relationship between spatially separated brain regions) in two distinct subnetworks involving: 1) the orbitofrontal cortex, temporal poles and the subgenual anterior cortex, and 2) the lingual and postcentral gyri. Another network, formed by connections between thalamic and occipital regions showed significant increase in FC. Tao et al (2017) are consistent with Moreira et al (2017) above. They describe, in OCD patients, abnormality in the lingua gyrus and the precuneus (part of the post central gyrus). Gan et al (2017) also found widely distributed abnormality of white matter. Thus, it is clear OCD is associated with more widely distributed abnormality than previously grasped. In about half patients with OCD the symptoms commence gradually, usually in childhood. In the other half, symptoms commence after a traumatic event (TE), usually in later life. Patients without TE may have bilateral grey matter volume increases in putamen and the central tegmental tract of the brainstem, while those with TE may have grey matter volume increase in the right anterior cerebellum (Real et al, 2016). Thus, the possibly of different pathophysiologies, depending on etiology. Immune factors An OCD-like disorder is caused in childhood by streptococcal infections - termed PANDAS (Paediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal infections). A large percentage of children who have suffered this Pridmore S. A role for immune factors in the aetiology OCD continues to be explored (Rodriguez et al, 2017) Current theories OCD is yet to be fully understood. One recent theory proposes a connection between disgust and OCD. Disgust is a basic human emotion, which may have an evolutionary function: the avoidance of contamination and disease. Functional imaging indicates that the neurocircuitry of OCD and disgust are similar. This would fit with OCD in which there are contamination concerns. Other current theories include “not just right experiences” (Coles et al, 2010), “failure of the ability to terminate improbable but grave danger concerns” (Woody and Szechtman, 2010), “an inflated sense of responsibility” (Smari et al, 2010), an increased sense of “incompleteness” (Belloch et al, 2016), and “difficulties in decision making” (Pushkarskaya et al, 2017). A theory of the molecular etiology of OCD suggests an alteration of dendrite formation, mediated by insulin and insulin-related signalling (van de Vondervoort et al, 2016). Psychological therapy Exposure and response prevention (ERP). Exposure consists of either self- or therapist-guided confrontation with the feared object or circumstances. Response prevention: once confrontation has been achieved, patients are asked to refrain from performing rituals. In thought stopping the patient (or initially the therapist) applies a stimulus which counteracts or interrupts the obsessional preoccupation. Common techniques include shouting “stop” or applying an aversive stimulus such as a sting on the wrist with an elastic band. Eventually, shouting or stinging can be replaced by less dramatic act, such as clenching a fist, at which point thought stopping can be performed unnoticed, in public settings. Behavioural therapy is as effective as pharmacotherapy, and neuroimaging studies show the same changes in cerebral metabolism with successful behaviour therapy as with successful pharmacotherapy (Swartz et al, 1996). However, both are ineffective in 25% of OCD patients. Behavioural therapy has an advantage over pharmacotherapy as the beneficial effects last longer after therapy has ceased. However, behaviour therapy can be difficult to apply if the patient does not have overt rituals (that is, if the symptoms include mental rituals and obsessional slowness). This approach is unacceptable to some patients and ineffective in others.
8 of 10 - Review by L. Gonzales
Votes: 284 votes
Total customer reviews: 284